Clinical Trials Logo

Clinical Trial Summary

This study is divided into two stages: the first stage is a dose verification trial, with a multicenter, open, single arm trial design, which is planned to enroll 10 children with general anesthesia surgery (all using HR020602 injection); the second stage is designed as a multicenter, randomized, double-blind, parallel control trial with positive drugs, which is planned to include 20 children with general anesthesia surgery in the test group and 20 children in the control group. There should be at least 15 patients in each of [2,12] and [12,18)age groups.

Clinical Trial Description


Study Design

NCT number NCT04867343
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Yang Zhang
Phone +0518-82342973
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date May 10, 2021
Completion date September 30, 2021